Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study-Reference-Cited by-同舟云学术

Safety of FFR-guided revascularisation deferral in Anatomically prognostiC diseasE (FACE: CARDIOGROUP V STUDY): A prospective multicentre study

Published:2018-11 Issue: Volume:270 Page:107-112
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Barbero Umberto^ORCID,D'Ascenzo Fabrizio,Campo Gianluca,Kleczyński Paweł,Dziewierz Artur^ORCID,Menozzi Mila^ORCID,Jiménez Díaz Victor A.^ORCID,Cerrato Enrico,Raposeiras-Roubín Sergio,Ielasi Alfonso,Rognoni Andrea,Fineschi Massimo,Kanji Rahim,Jaguszewski Milosz J.,Picchi Andrea,Andò Giuseppe^ORCID,Soraci Emmanuele^ORCID,Mancone Massimo,Sardella Gennaro,Calcagno Simone,Gallo Francesco,Huczek Zenon,Krakowian Marcin,Verardi Roberto,Montefusco Antonio,Omedè Pierluigi,Lococo Marco,Moretti Claudio,D'Amico Maurizio,Rigattieri Stefano^ORCID,Gaita Fiorenzo,Rinaldi Mauro,Escaned Javier

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference34 articles.

1. Predicting outcome in the COURAGE trial (clinical outcomes utilizing revascularization and aggressive drug evaluation): coronary anatomy versus ischemia;Mancini;J. Am. Coll. Cardiol. Intv.,2014

2. Incidence and management of restenosis after treatment of unprotected left main disease with second-generation drug-eluting stents (from failure in left main study with 2nd generation stents-cardiogroup III study);D'Ascenzo;Am. J. Cardiol.,2017

3. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy;Shaw;Circulation,2008

4. The search for optimal dual antiplatelet therapy after PCI: fine-tuning of initiation and duration;Lüscher;Eur. Heart J.,2016

5. Impact of an optical coherence tomography guided approach in acute coronary syndromes: a propensity matched analysis from the international FORMIDABLE-CARDIOGROUP IV and USZ registry;Iannaccone;Catheter. Cardiovasc. Interv.,2017

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Impact of Renal Function on 5‐Year Outcomes After Fractional Flow Reserve‐Guided Deferral of Revascularization;Journal of the American Heart Association;2023-10-17

2. Effects of hemodialysis and reduced estimated glomerular filtration rate in nonhemodialysis on clinical outcomes after fractional flow reserve-guided deferral of revascularization;Medicine;2022-05-20

3. Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesions;Journal of Cardiovascular Medicine;2021-10-01

4. Fractional flow reserve-guided treatment in coronary artery disease: Clinical practice;Advances in Clinical and Experimental Medicine;2021-09-09

5. Adenosine and fractional flow reserve: no reason to be afraid anymore!;Minerva Cardiology and Angiology;2021-09